133 related articles for article (PubMed ID: 36178736)
1. New hope from OPERA trial for surgically fit rectal cancer patients who wish to have organ preservation.
Myint AS
Colorectal Dis; 2022 Sep; 24(9):1026-1027. PubMed ID: 36178736
[No Abstract] [Full Text] [Related]
2. 2023 A new French revolution: Organ preservation for rectal cancer.
Gérard JP
Cancer Radiother; 2024 Apr; 28(2):143-144. PubMed ID: 38508953
[No Abstract] [Full Text] [Related]
3. Salvage Surgery With Organ Preservation for Patients With Local Regrowth After Watch and Wait: Is It Still Possible?
Fernandez LM; Figueiredo NL; Habr-Gama A; São Julião GP; Vieira P; Vailati BB; Nasir I; Parés O; Santiago I; Castillo-Martin M; Carvalho C; Parvaiz A; Perez RO
Dis Colon Rectum; 2020 Aug; 63(8):1053-1062. PubMed ID: 32692070
[TBL] [Abstract][Full Text] [Related]
4. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
5. The role of chemoradiotherapy in organ preservation for rectal cancer.
Xie L; Chen Q; Zhu J
Ann Oncol; 2023 Apr; 34(4):440. PubMed ID: 36549588
[No Abstract] [Full Text] [Related]
6. [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center].
Wu A; Wang L; Du C; Peng Y; Yao Y; Zhao J; Zhan T; Cai Y; Li Y; Sun Y; Ji J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):417-424. PubMed ID: 28440523
[TBL] [Abstract][Full Text] [Related]
7. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer.
Creavin B; Ryan E; Martin ST; Hanly A; O'Connell PR; Sheahan K; Winter DC
Br J Cancer; 2017 Jan; 116(2):169-174. PubMed ID: 27997526
[TBL] [Abstract][Full Text] [Related]
8. Is organ preservation in rectal cancer ready for prime time?
Tekkis P; Tait D; Cunningham D; Brown G
Lancet; 2018 Jun; 391(10139):2480-2482. PubMed ID: 29976455
[No Abstract] [Full Text] [Related]
9. Radio- or Chemotherapy Dose Escalation for Organ Preservation in Rectal Cancer?
Socha J; Żółciak-Siwińska A; Bujko K
J Clin Oncol; 2023 Jan; 41(2):417. PubMed ID: 36126242
[No Abstract] [Full Text] [Related]
10. Organ preservation in rectal cancer: towards the norm rather than the exception.
Roxburgh CS
Br J Surg; 2021 Jul; 108(7):745-747. PubMed ID: 34195801
[No Abstract] [Full Text] [Related]
11. Hemi-levator excision to provide greater sphincter preservation in low rectal cancer.
AlAsari SF; Lim D; Kim NK
Int J Colorectal Dis; 2013 Dec; 28(12):1727-8. PubMed ID: 23456300
[No Abstract] [Full Text] [Related]
12. Locally advanced rectal cancer: Preliminary results of rectal preservation after neoadjuvant chemoradiotherapy.
Vaccaro CA; Yazyi FJ; Ojra Quintana G; Santino JP; Sardi ME; Beder D; Tognelli J; Bonadeo F; Lastiri JM; Rossi GL
Cir Esp; 2016 May; 94(5):274-9. PubMed ID: 26980259
[TBL] [Abstract][Full Text] [Related]
13. [Neoadjuvant treatment for rectal cancer].
Bachet JB; Benoist S; Mas L; Huguet F
Bull Cancer; 2021 Sep; 108(9):855-867. PubMed ID: 34140155
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic intersphincteric resection of rectal cancer with posterior vaginal wall excision without hysterectomy.
Fukui Y; Kuroyanagi H; Toda S; Tomizawa K; Hanaoka Y; Matoba S
Tech Coloproctol; 2018 Sep; 22(9):719-724. PubMed ID: 30324408
[No Abstract] [Full Text] [Related]
15. Comment on "Organ Preservation in cT2N0 Rectal Cancer After Neoadjuvant Chemoradiation Therapy".
Kanemoto Y; Kurokawa T; Tanimoto T
Ann Surg; 2019 Dec; 270(6):e118-e119. PubMed ID: 31425284
[No Abstract] [Full Text] [Related]
16. RE: Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.
Bujko K; Rutkowski A
J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27986886
[No Abstract] [Full Text] [Related]
17. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial.
Rullier E; Rouanet P; Tuech JJ; Valverde A; Lelong B; Rivoire M; Faucheron JL; Jafari M; Portier G; Meunier B; Sileznieff I; Prudhomme M; Marchal F; Pocard M; Pezet D; Rullier A; Vendrely V; Denost Q; Asselineau J; Doussau A
Lancet; 2017 Jul; 390(10093):469-479. PubMed ID: 28601342
[TBL] [Abstract][Full Text] [Related]
18. Organ preservation in rectal cancer: review of contemporary management.
Fleming C; Vendrely V; Rullier E; Denost Q
Br J Surg; 2022 Jul; 109(8):695-703. PubMed ID: 35640118
[TBL] [Abstract][Full Text] [Related]
19. New hope from OPERA trial for surgically fit rectal cancer patients who wish to have organ preservation.
Myint AS; Dhadda AS; Stewart A; Mills J; Sripadam R; Rao C; Hershman MJ; Pritchard DM; Gerard JP
Colorectal Dis; 2022 Jul; ():. PubMed ID: 35881029
[No Abstract] [Full Text] [Related]
20. Manuscript 'close shave' margins do not increase rectal cancer recurrence after sphincter-saving surgery without neoadjuvant therapy by Lim et al.
Thomusch O; Ruf G
Int J Colorectal Dis; 2012 Dec; 27(12):1691-2. PubMed ID: 23011544
[No Abstract] [Full Text] [Related]
[Next] [New Search]
